71 related articles for article (PubMed ID: 29686398)
1. Taking aim at transcriptional regulator targets.
Koch L
Nat Rev Genet; 2018 Jun; 19(6):328. PubMed ID: 29686398
[No Abstract] [Full Text] [Related]
2. Drug targeting of dysregulated transcription in Huntington's disease.
Kazantsev AG; Hersch SM
Prog Neurobiol; 2007 Nov; 83(4):249-59. PubMed ID: 17379386
[TBL] [Abstract][Full Text] [Related]
3. Absence of mutations in the key megakaryocyte transcriptional regulator FOG-1 in patients with idiopathic myelofibrosis.
Fisher C; Steensma D; Janmohamed R; Kaczmarski R; Reilly JT; Vyas P
Br J Haematol; 2004 Sep; 126(5):750-2. PubMed ID: 15327530
[No Abstract] [Full Text] [Related]
4. Cooperative activation of transcription by autoimmune regulator AIRE and CBP.
Pitkänen J; Rebane A; Rowell J; Murumägi A; Ströbel P; Möll K; Saare M; Heikkilä J; Doucas V; Marx A; Peterson P
Biochem Biophys Res Commun; 2005 Aug; 333(3):944-53. PubMed ID: 15964547
[TBL] [Abstract][Full Text] [Related]
5. [STAT: transcriptional regulator of cytokine signaling].
Sekine K; Kim KW; Miyajima A
Tanpakushitsu Kakusan Koso; 2003 Dec; 48(16):2241-6. PubMed ID: 14661581
[No Abstract] [Full Text] [Related]
6. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
7. The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD.
Bailey P; Sartorelli V; Hamamori Y; Muscat GE
Nucleic Acids Res; 1998 Dec; 26(23):5501-10. PubMed ID: 9826778
[TBL] [Abstract][Full Text] [Related]
8. Evolution of a transcriptional regulator from a transmembrane nucleoporin.
Franks TM; Benner C; Narvaiza I; Marchetto MC; Young JM; Malik HS; Gage FH; Hetzer MW
Genes Dev; 2016 May; 30(10):1155-71. PubMed ID: 27198230
[TBL] [Abstract][Full Text] [Related]
9. Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain.
Gibbons RJ; Bachoo S; Picketts DJ; Aftimos S; Asenbauer B; Bergoffen J; Berry SA; Dahl N; Fryer A; Keppler K; Kurosawa K; Levin ML; Masuno M; Neri G; Pierpont ME; Slaney SF; Higgs DR
Nat Genet; 1997 Oct; 17(2):146-8. PubMed ID: 9326931
[No Abstract] [Full Text] [Related]
10. The transcriptional role of PML and the nuclear body.
Zhong S; Salomoni P; Pandolfi PP
Nat Cell Biol; 2000 May; 2(5):E85-90. PubMed ID: 10806494
[TBL] [Abstract][Full Text] [Related]
11. Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets.
Párrizas M; Maestro MA; Boj SF; Paniagua A; Casamitjana R; Gomis R; Rivera F; Ferrer J
Mol Cell Biol; 2001 May; 21(9):3234-43. PubMed ID: 11287626
[TBL] [Abstract][Full Text] [Related]
12. Regulation of a transcription factor network required for differentiation and metabolism.
Duncan SA; Navas MA; Dufort D; Rossant J; Stoffel M
Science; 1998 Jul; 281(5377):692-5. PubMed ID: 9685261
[TBL] [Abstract][Full Text] [Related]
13. The basic helix-loop-helix, leucine zipper transcription factor, USF (upstream stimulatory factor), is a key regulator of SF-1 (steroidogenic factor-1) gene expression in pituitary gonadotrope and steroidogenic cells.
Harris AN; Mellon PL
Mol Endocrinol; 1998 May; 12(5):714-26. PubMed ID: 9605934
[TBL] [Abstract][Full Text] [Related]
14. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
Goto Y; Hayashi R; Muramatsu T; Ogawa H; Eguchi I; Oshida Y; Ohtani K; Yoshida K
Biochim Biophys Acta; 2006; 1759(1-2):60-8. PubMed ID: 16580749
[TBL] [Abstract][Full Text] [Related]
15. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression.
Kritis AA; Ktistaki E; Barda D; Zannis VI; Talianidis I
Nucleic Acids Res; 1993 Dec; 21(25):5882-9. PubMed ID: 8290348
[TBL] [Abstract][Full Text] [Related]
16. RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX.
Michaelson JS; Leder P
J Cell Sci; 2003 Jan; 116(Pt 2):345-52. PubMed ID: 12482920
[TBL] [Abstract][Full Text] [Related]
17. [P-TEFb and Brd4: actors of the transcription pause release as therapeutical targets].
Furlan A; Agbazahou F; Henry M; Gonzalez-Pisfil M; Le Nézet C; Champelovier D; Fournier M; Vandenbunder B; Bidaux G; Héliot L
Med Sci (Paris); 2018; 34(8-9):685-692. PubMed ID: 30230450
[TBL] [Abstract][Full Text] [Related]
18. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation.
Devgan V; Mammucari C; Millar SE; Brisken C; Dotto GP
Genes Dev; 2005 Jun; 19(12):1485-95. PubMed ID: 15964998
[TBL] [Abstract][Full Text] [Related]
19. Phospho-BRD4: transcription plasticity and drug targeting.
Chiang CM
Drug Discov Today Technol; 2016 Mar; 19():17-22. PubMed ID: 27769352
[TBL] [Abstract][Full Text] [Related]
20. Characterization of DNA binding, transcriptional activation, and regulated nuclear association of recombinant human NFATp.
Kim LJ; Ferguson HA; Seto AG; Goodrich JA
BMC Immunol; 2000; 1():1. PubMed ID: 11231878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
